Stay updated on Oral Ifetroban for AERD Clinical Trial
Sign up to get notified when there's something new on the Oral Ifetroban for AERD Clinical Trial page.

Latest updates to the Oral Ifetroban for AERD Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov page footer now displays site revision v3.8.1 instead of v3.8.0.SummaryDifference0.1%

- Check8 days agoChange DetectedThe study record for the completed phase 2 oral ifetroban trial in aspirin-exacerbated respiratory disease is displayed, including its eligibility criteria, study locations, interventions, and outcome measures. Results and study documents are also available.SummaryDifference56%

- Check15 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check29 days agoChange DetectedAn NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the site revision advances from v3.7.1 to v3.7.2. The study page still displays a 403 error.SummaryDifference1%

- Check43 days agoChange DetectedThe footer revision advances from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study records with a generic error screen and a Home link; this prevents viewing the trial's details and related documents on this page.SummaryDifference18%

Stay in the know with updates to Oral Ifetroban for AERD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Ifetroban for AERD Clinical Trial page.